BioAssay Works will be exhibiting in Hall 3 / D19-7 during MEDICA, November 16-19. Come talk with our team about custom lateral flow assay (LFA) development and manufacturing across healthcare, veterinary, environmental, and food testing.

This year, we’re spotlighting a growing priority for biopharmaceutical manufacturers: biotherapeutic identity testing. As biologic portfolios expand and formats like ADCs add new layers of complexity, lot-release identity testing has become a mission-critical — and increasingly demanding — specificity challenge.

We unpack how this space has evolved (and where it’s heading) in two recent articles:

• Biotherapeutic Identity Testing: From Novel Concept to Mission-Critical Manufacturing Requirement
• Two Molecules, One Test: What ADCs Demand from Identity Testing

Attending MEDICA 2026? Stop by our booth in Hall 3 / D19-7 — we’d love to connect.

See you in Düsseldorf!